EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H28O6 |
| Net Charge | 0 |
| Average Mass | 424.493 |
| Monoisotopic Mass | 424.18859 |
| SMILES | [H][C@@]1(c2c(O)cccc2O)CC(=O)c2c(O)cc(O)c(C[C@@H](CC=C(C)C)C(=C)C)c2O1 |
| InChI | InChI=1S/C25H28O6/c1-13(2)8-9-15(14(3)4)10-16-19(28)11-20(29)24-21(30)12-22(31-25(16)24)23-17(26)6-5-7-18(23)27/h5-8,11,15,22,26-29H,3,9-10,12H2,1-2,4H3/t15-,22+/m1/s1 |
| InChIKey | FPUREMWTZVLZBZ-QRQCRPRQSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Artemisia indica (ncbitaxon:318067) | stem (BTO:0001300) | PubMed (9748386) | |
| Sophora exigua (IPNI:518828-1) | root (BTO:0001188) | DOI (10.1016/0031-9422(92)80056-K) |
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| Application: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| exiguaflavanone A (CHEBI:65891) has functional parent (2S)-flavanone (CHEBI:15606) |
| exiguaflavanone A (CHEBI:65891) has role antimalarial (CHEBI:38068) |
| exiguaflavanone A (CHEBI:65891) has role metabolite (CHEBI:25212) |
| exiguaflavanone A (CHEBI:65891) is a tetrahydroxyflavanone (CHEBI:38742) |
| IUPAC Name |
|---|
| (2S)-2-(2,6-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one |
| Manual Xrefs | Databases |
|---|---|
| LMPK12140111 | LIPID MAPS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5362663 | Reaxys |
| Citations |
|---|